ストックスクリーナーアプリを入手
21.00
5.79%
1.15
アフターアワーズ：
21.00
前日終値:
$19.85
開ける：
$20.5
24時間の取引高:
10,218
Relative Volume:
0.30
時価総額：
$37.22M
収益：
$8.96M
当期純損益:
$-9.63M
株価収益率:
-17.75
EPS:
-1.1831
ネットキャッシュフロー:
$-15.88M
1週間 パフォーマンス:
-2.23%
1か月 パフォーマンス:
+0.19%
6か月 パフォーマンス:
+22,217%
1年 パフォーマンス:
+2,590%
1日の値動き範囲:
$20.45
$21.29
1週間の範囲:
$19.50
$23.45
52週間の値動き範囲:
$0.0866
$31.00
Palatin Technologies Inc. Stock (PTN) Company Profile
名前
Palatin Technologies Inc.
セクター
電話
609-495-2200
住所
Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ
Compare PTN vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PTN
Palatin Technologies Inc.
|
21.00 | 35.18M | 8.96M | -9.63M | -15.88M | -1.1831 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-12 | 開始されました | Laidlaw | Buy |
| 2025-12-03 | 開始されました | Alliance Global Partners | Buy |
| 2015-06-05 | 繰り返されました | Canaccord Genuity | Buy |
| 2015-01-12 | 繰り返されました | ROTH Capital | Buy |
| 2012-05-23 | 開始されました | Noble Financial | Buy |
| 2007-01-23 | 開始されました | Next Generation | Buy |
すべてを表示
Palatin Technologies Inc. (PTN) 最新ニュース
Palatin Technologies stock faces volatility amid bremelanotide sales updates and pipeline advancemen - AD HOC NEWS
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN) - TradingView
Palatin Technologies (PTNT) Insider Trading Activity 2026 $PTNT - MarketBeat
Palatin Technologies (PTNT) 10K Form and SEC Filings 2026 $PTNT - MarketBeat
PTN Earnings History & Surprises | EPS & Revenue Results | PALATIN TECHNOLOGIES INC (NYSEARCA:PTN) - ChartMill
PTN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
PTN Technical Analysis | Trend, Signals & Chart Patterns | PALATIN TECHNOLOGIES INC (NYSEARCA:PTN) - ChartMill
PTN Stock Price, Quote & Chart | PALATIN TECHNOLOGIES INC (NYSEARCA:PTN) - ChartMill
Operating cash flow per share of Palatin Technologies, Inc. – LSE:0KF3 - TradingView
EBIT per share of Palatin Technologies, Inc. – LSE:0KF3 - TradingView
Dry Eye Disease Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Palatin Technologies, Novaliq, mc2 therapeutics - Barchart.com
PTN Should I Buy - Intellectia AI
Palatin Techs (PTN) Stock Analysis Report | Financials & Insights - Benzinga España
Palatin Technologies (PINK:PTNT) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
Palatin to test 2 obesity-targeting drugs for PWS in clinical trials this year - Prader-Willi Syndrome News
Palatin Technologies Q2 Earnings Call Highlights - Defense World
Palatin Technologies’ Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN) - TipRanks
Palatin Technologies, Inc. (AMEX:PTN) Q2 2026 Earnings Call Transcript - Insider Monkey
Palatin Technologies' Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN) - TradingView
Earnings call transcript: Palatin Technologies Q2 2026 reveals challenges By Investing.com - Investing.com South Africa
Palatin Technologies Inc (PTN) Q2 2026 Earnings Call Highlights: Strategic Advances Amid Rising Losses - GuruFocus
Earnings call transcript: Palatin Technologies Q2 2026 reveals challenges - Investing.com Australia
PTN: Strengthened cash position and advanced rare obesity pipeline with key clinical milestones ahead - TradingView
PALATIN TECHNOLOGIES INC SEC 10-Q Report - TradingView
Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update - The Malaysian Reserve
PTN | Palatin Technologies, Inc. Analyst Forecasts - Quiver Quantitative
PTN | Palatin Technologies, Inc. Insider Trading - Quiver Quantitative
Palatin Technologies Q2 revenue rises yr/yr, net loss widens - TradingView
PTN: MC4R obesity programs advance to clinical trials as cash position strengthens and net loss widens - TradingView
Palatin funds new obesity drug trials for hypothalamic obesity, PWS - Stock Titan
Palantin Technologies to enact 1-for-50 reverse stock split - MSN
Head-To-Head Contrast: Palatin Technologies (PINK:PTNT) vs. Akorn (OTCMKTS:AKRXQ) - Defense World
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) & Palatin Technologies (PINK:PTNT) Critical Analysis - Defense World
Palatin initiated with a Buy at LaidlawRhythm Pharmaceuticals - MSN
The Truth About Palatin Technologies (PTN): Tiny Biotech, Huge Hype – But Is It Worth Your Money? - AD HOC NEWS
Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Palatin Technologies Targets Hypothalamic Obesity as Next Frontier Beyond GLP-1s (NYSE: PTN) - TradingView — Track All Markets
Here's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock Now - MSN
Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Palatin Technologies (PTNT) Stock Forecast and Price Target 2026 - MarketBeat
Palatin Technologies (PTN) officer reports Form 4 tax-withheld shares - Stock Titan
Palatin Technologies (PTN) CEO Carl Spana details tax share withholdings - Stock Titan
Palatin finishes phase 2 trial in obesity treatment study - MSN
Palatin Technologies (PINK:PTNT) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Palatin Technologies (PTN) CFO/COO reports 565-share insider stock sale - Stock Titan
PTN (PTN) holder plans Rule 144 sale of 565 common shares - Stock Titan
Comparing Clever Leaves (NASDAQ:CLVR) and Palatin Technologies (PINK:PTNT) - Defense World
Palatin Technologies, Inc.(NYSEAM: PTN) added to S&P TMI Index - marketscreener.com
Decliners Report: How Palatin Technologies Inc. (PTN) stock reacts to new regulationsEarnings Miss & Long Hold Capital Preservation Tips - Улправда
Palatin Technologies Earnings Notes - Trefis
How Palatin Technologies Inc. (PTN) stock reacts to new regulationsTrade Risk Assessment & Capital Efficiency Focused Strategies - Улправда
Palatin Technologies Inc. (PTN) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):